Literature DB >> 2982922

Incidence of anti-intermediate filament antibody in serum samples of students with suspected glandular fever.

P K Kataaha, E J Holborow, J M Edwards.   

Abstract

Serum samples from 40 students with suspected infectious mononucleosis were tested for the presence of antibodies to intermediate filaments (AIFA) of the cytoskeleton. Twenty had antibodies to the Epstein-Barr virus capsid antigen before their illness, and during it their sera remained negative by the Paul-Bunnell test. The other 20 patients did not have antibodies to the Epstein-Barr virus capsid antigen before their illness and seroconverted during the illness. These patients (true infectious mononucleosis group) developed positive Paul-Bunnell tests. Sera from normal subjects (blood donors) were also tested for AIFA. AIFA was present in titres greater than 1/10 in 80% of the infectious mononucleosis group (mean titre 1/40-1/80), 10% of the Paul-Bunnell negative glandular fever group, and 8.5% of the normal blood donors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982922      PMCID: PMC499140          DOI: 10.1136/jcp.38.3.351

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Antinuclear factor and other antibodies in blood and liver diseases.

Authors:  E J HOLBOROW; G L ASHERSON; G D JOHNSON; R D BARNES; D S CARMICHAEL
Journal:  Br Med J       Date:  1963-03-09

2.  Measurement of heterophil antibody and antibodies to EB viral capsid antigen IgG and IgM in suspected cases of infectious mononucleosis.

Authors:  J M Blake; J M Edwards; W Fletcher; D A McSwiggan; M S Pereira
Journal:  J Clin Pathol       Date:  1976-09       Impact factor: 3.411

3.  Autoantibody to "intermediate filament" in infectious mononucleosis.

Authors:  E Linder; P Kurki; L C Andersson
Journal:  Clin Immunol Immunopathol       Date:  1979-12

4.  Characterization of human smooth muscle autoantibodies reacting with cytoplasmic intermediate filaments.

Authors:  P Kurki; I Virtanen; S Stenman; E Linder
Journal:  Clin Immunol Immunopathol       Date:  1978-12

5.  Different intermediate-sized filaments distinguished by immunofluorescence microscopy.

Authors:  W W Franke; E Schmid; M Osborn; K Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  The occurrence of autoantibodies in infectious mononucleosis.

Authors:  R N Sutton; R T Emond; D B Thomas; D Doniach
Journal:  Clin Exp Immunol       Date:  1974-07       Impact factor: 4.330

7.  Cross-reactivity between Thy-1 and a component of intermediate filaments demonstrated using a monoclonal antibody.

Authors:  R Dulbecco; M Unger; M Bologna; H Battifora; P Syka; S Okada
Journal:  Nature       Date:  1981-08-20       Impact factor: 49.962

8.  Studies on the macroglobulins of human serum. I. Polyclonal immunoglobulin class M (IgM) increase in infectious mononucleosis.

Authors:  F A Wollheim; R C Williams
Journal:  N Engl J Med       Date:  1966-01-13       Impact factor: 91.245

9.  Smooth muscle autoantibodies in infectious mononucleosis.

Authors:  E J Holborow; E H Hemsted; S V Mead
Journal:  Br Med J       Date:  1973-08-11

10.  Antibody to intermediate filaments of the cytoskeleton.

Authors:  O A Osung; M Chandra; E J Holborow
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

View more
  3 in total

1.  Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1.

Authors:  J H Vaughan; J R Valbracht; M D Nguyen; H H Handley; R S Smith; K Patrick; G H Rhodes
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

2.  Anti-intermediate filament antibodies, antikeratin antibody, and antiperinuclear factor in rheumatoid arthritis and infectious mononucleosis.

Authors:  P K Kataaha; S M Mortazavi-Milani; G Russell; E J Holborow
Journal:  Ann Rheum Dis       Date:  1985-07       Impact factor: 19.103

3.  Prevention of MS Requires Intervention on the Causes of the Disease: Reconciling Genes, Epigenetics, and Epstein Barr Virus.

Authors:  Patrick K A Kearns
Journal:  Front Neurol       Date:  2022-02-22       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.